Dr. Ehsan Kamani is a pioneering researcher and medical professional in the field of low-level laser therapy (LLLT), particularly its applications in viral infections, including COVID-19, and its potential to mitigate the side effects of vaccines. His work is based on extensive research into the therapeutic effects of lasers with wavelengths ranging from 450 to 910 nanometers, with particular attention to the blue and yellow light spectrums. Dr. Kamani's contributions to the medical and scientific communities are most notable for his innovative application of low-power laser light in treating and managing both viral infections and vaccine-related complications. His research suggests that low-level lasers can help mitigate vaccine side effects by promoting proper blood vessel formation, enhancing blood cell production, regulating immune cells, reducing inflammation and infection, and improving overall immune system function. Dr. Kamani's published work includes studies such as Role of Low-Power Blue Laser With a Wavelength of 405 Nm in Increasing the Level of Nitric Oxide in Increasing the Resistance of Cells to the Virus (COVID-19) (2020), and Application of Laser Blue Light with a Wavelength of 405 nm in the Treatment of Patients with COVID-19 (2020). These studies explore the relationship between low-level laser therapy and COVID-19, highlighting its potential to increase nitric oxide levels, which can enhance the body's ability to resist viral infections and reduce viral mortality. Dr. Kamani's innovative approach involves using LLLT at various irradiation sites—acupuncture points, local irradiation, intravenous radiation, and radiation through the nose and ear—tailored to the patient's specific medical history and conditions. His therapeutic approach is based on the idea that low-level laser therapy can be a safe and effective treatment for about 80% of the complications associated with vaccines, offering a promising non-invasive alternative to address post-vaccination issues. Through his years of research and clinical trials, Dr. Kamani has become a recognized expert in photobiomodulation therapy, particularly in its application to viral diseases and vaccine-related complications, offering a new perspective on the use of lasers in modern medicine.
Dr. Ehsan Kamani is a pioneering researcher and medical professional in the field of low-level laser therapy (LLLT), particularly its applications in viral infections, including COVID-19, and its potential to mitigate the side effects of vaccines Through his years of research and clinical trials, Dr. Kamani has become a recognized expert in photobiomodulation therapy, particularly in its application to viral diseases and vaccine-related complications, offering a new perspective on the use of lasers in modern medicine
Let's stop the side effects of the Covid-19 vaccine with the new science of low level laser therapy
Dear researchers and doctors, As we know, based on information and articles, irreparable complications have occurred worldwide due to the injection of the Covid vaccine.These complications include diabetes, cancer, internal diseases, heart disease, or even heart and stroke in all age groups.This is a statistical disaster worldwide.Based on my many years of study on Low-level lasers with a wavelength range of 450 to 910 nanometers, like a mother holding her child, this wavelength range with a power of 50 to 250 milliwatts can save vaccine side effects. This mentioned interval causes: Creating proper blood vessels Increasing blood cell production Controlling immune cells Reducing inflammation and infection Increasing the body's immunity in the right direction Radiation inputs vary based on the patient's history and complications: Acupuncture points,Local radiation,Intravenous radiation and Radiation through the nose and ear This treatment method can be safely said to be effective in 80% of the complications of this fatal vaccine, and using the appropriate dose, it is the safest and most effective method available.